Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01459653 · FLOW

Participant flow

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor · Source last updated 2016-01-11

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Cancer patients treated with chemotherapy and who are prescribed commercially available filgrastim biosimilar for primary or secondary prophylaxis for FN.
    id
    FG000
    title
    EP2006
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        1496
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        828
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        668
      type
      NOT COMPLETED
    title
    Overall Study
Complete source fields
groups
  1. description
    Cancer patients treated with chemotherapy and who are prescribed commercially available filgrastim biosimilar for primary or secondary prophylaxis for FN.
    id
    FG000
    title
    EP2006
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        1496
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        828
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        668
      type
      NOT COMPLETED
    title
    Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice